Transcriptional regulation by growth hormone (GH) represents the culmination of signal transduction pathways that are initiated by the cell surface GH receptor and are targeted to the nucleus. Recent studies have demonstrated that the activated GH receptor can stimulate Stat1, a cytoplasmic transcription factor that becomes tyrosine phosphorylated and translocates to the nucleus, where it can interact with specific DNA sequences to modulate gene expression. GH also has been found to induce protein binding to a portion of the rat serine protease inhibitor (Spi) 2.1 gene promoter that is required for GH-induced transcription of Spi 2.1. Using GH-deficient hypophysectomized rats as a model, we show that GH treatment rapidly and potently induces both nuclear Spi 2.1 mRNA expression in the liver and specific nuclear protein binding to a 45-bp segment of the Spi 2.1 gene promoter. A GH-inducible gel-shifted complex appears within 15 min of systemic hormone administration and can be inhibited by an antiphosphotyrosine monoclonal antibody but is not blocked by a polyclonal antiserum to Stat1, Stat3, or Stat4, even though the nucleotide sequence contains two gamma interferon-activated sequence-like elements that could interact with STAT proteins. By Southwestern (DNA-protein) blot analysis, ϳ41-and 35-kDa GH-inducible proteins were detected in hepatic nuclear extracts with the Spi 2.1 DNA probe. Thus, a GH-activated signaling pathway stimulates Spi 2.1 gene expression through a unique mechanism that does not appear to involve known members of the STAT family of transcription factors.
Growth hormone (GH), a 191-amino-acid polypeptide secreted by the adenohypophysis, exerts a variety of growthpromoting (4, 49) and metabolic (10, 28) effects in mammals. Although some of these actions are mediated by stimulation of insulin-like growth factor-I (IGF-I) (9) , many of the effects of GH do not require this growth factor (25) . GH initiates its biological actions by binding to and activating a specific cell surface receptor (56) . The GH receptor is a member of the cytokine/hematopoietin family and shares structural motifs with other members of this family (21) . Hormone binding induces GH receptor dimerization (6, 16) , and the dimerized receptor binds to and activates JAK2 (1, 32) , an intracellular tyrosine protein kinase that can also interact with receptors for gamma interferon (42, 43, 55) , erythropoietin (56) , prolactin (12, 34) , and other members of the cytokine/hematopoietin receptor family (45, 47) . Previous studies on the gamma interferon signal transduction pathway have identified a cytoplasmic protein, termed Stat1 (formerly Stat91, for signal transducer and activator of transcription), that undergoes tyrosine phosphorylation and nuclear translocation in response to receptor activation (8, 40) . Stat1 binds as a dimer to a specific DNA element (gamma interferon-activated sequence [GAS] ), consisting minimally of a TT(N) 5 AA motif (8) , and binding results in activation of target gene transcription (41) . Stat1 also can form heterodimers with other members of the STAT family, such as Stat2 (p113), when both are activated by the alpha/ beta interferon signaling pathway (8, 38) . This so-called ISGF3 (interferon-stimulated gene factor 3) complex also includes a DNA-binding subunit termed p48 and interacts with a cisacting element, the interferon-stimulated response element, to activate transcription of alpha/beta interferon-regulated genes (7, 14, 15) .
GH acutely stimulates the transcription of several target genes, including c-fos (11, 20, 24, 47) and the IGF-I (2) and serine protease inhibitor (Spi) 2.1 (59, 60) genes, but the ciselements and trans-acting factors involved in GH-activated gene expression remain undefined. Transcription of the earlyresponse gene, c-fos, is induced by a variety of cellular growth factors through cis-acting elements in the c-fos 5Ј flanking region, such as the serum response element (53) and SIE (c-sis-inducible element). The SIE is capable of binding a transcriptional activator, c-sis-inducible factor, in response to epidermal growth factor (33, 35) , platelet-derived growth factor (44, 54) , or GH (23) (previously identified as GHIF, for GHinducible DNA-binding factor). Recent studies have demonstrated that both the c-sis-inducible factor and GHIF contain Stat1 (13, 18, 22, 23) .
A GH-inducible DNA-protein interaction also has been described for the rat Spi 2.1 gene (59) . Expression of Spi 2.1 is very low in hypophysectomized rats but can be stimulated by administration of GH (59, 60) . A GH-regulated DNase I-hypersensitive site is located in the 5Ј flanking region of the Spi 2.1 gene, and a GH-activated DNA-protein interaction has been identified by gel mobility shift assay using sequences residing between 103 and 147 bp 5Ј to the transcription start site (59) . This site also confers GH inducibility in transient transfection studies in primary hepatocytes (26, 59) . In this report, we show that the kinetics of GH-inducible nuclear protein binding to this segment of the Spi 2.1 gene promoter are rapid and coincide with activation of Spi 2.1 gene transcription. Analysis of the GH-inducible DNA-protein binding complex indicates that it does not contain members of the STAT family of transcription factors (8, 58, 61, 62) , suggesting a unique pathway of GH-mediated transcriptional control. Animal studies. Male Sprague-Dawley rats, hypophysectomized at 7 weeks of age, were purchased from Harlan Sprague-Dawley and were maintained at the Washington University Animal Care facility on a 12-h light/dark schedule with free access to food and drinking water (supplemented with 5% [wt/vol] dextrose). GH deficiency was confirmed by lack of growth or weight gain over the subsequent 10-to 14-day period. At 8 to 9 weeks of age, rats were given a single intraperitoneal injection of recombinant human GH (1.5 mg/kg in 0.2 ml of saline) or saline at 15, 30, 60, or 120 min prior to sacrifice. Livers were excised, weighed, and placed on ice, and portal veins were flushed with cold phosphatebuffered saline containing 1 mM Na 3 VO 4 . Extrahepatic tissue was dissected away, and the livers were minced and aliquoted for nuclear extraction and RNA analysis. All studies were approved by the Washington University Animal Studies Committee.
MATERIALS AND METHODS

Materials
RNA analysis. Liver nuclear RNA was isolated as previously described (5), quantitated by using spectrophotometric A 260 readings, and qualitatively assessed by agarose gel electrophoresis and ethidium bromide staining. Solution hybridization RNase protection assays were performed as described previously (2), using 5 g of nuclear RNA and [␣-
32 P]CTP-labeled antisense RNA probes containing exon 1 of the Spi 2.1 gene (59) or exon c of the rat albumin gene (37) . Protected RNA fragments were electrophoresed through 6% acrylamide-8.3 M urea gels and visualized by autoradiography. Results were quantitated with a Betascope 603 Betascanner.
Nuclear protein extraction. Rat liver nuclear proteins were extracted from hypophysectomized and GH-treated rats according to previously published methods with minor modifications (17, 52) . Protein concentration was quantitated by using a modified Bradford assay (Bio-Rad Laboratories, Hercules, Calif.). Nuclear extracts were aliquoted and immediately frozen in liquid nitrogen for storage.
Gel mobility shift assays. Gel mobility shift assays were performed by previously published methods (3, 29) . Radiolabeled double-stranded probes containing the GH-inducible cis-acting element from the rat Spi 2.1 gene (59), the high-affinity SIE (54) , and the Oct-1 consensus sequence (30) were prepared by filling in the 5Ј overhanging ends of annealed complementary oligonucleotides (shown in Table 1 ), using the Klenow fragment of DNA polymerase I, dCTP, dGTP, dTTP, and [␣-
32 P]dATP (36) . Unlabeled competitor oligonucleotides were prepared similarly (see Table 1 for sequences). Nuclear extract was preincubated for 15 min on ice with 2 g of poly(dI-dC), with or without unlabeled specific or nonspecific competitor DNA or antibody, and binding buffer (50 mM NaCl, 50 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, 2 mM dithiothreitol, 4 mM spermidine, 17.5% glycerol, 10 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid [HEPES], 2% bovine serum albumin) (31) . Approximately 5 ϫ 10 4 cpm (ϳ5 ng) of the appropriate 32 P-labeled probe was then added to the reaction mixture for 30 min on ice. Samples were analyzed on 5% nondenaturing polyacrylamide gels in 0.5ϫ Tris-borate-EDTA after preelectrophoresis for 1 h at 4ЊC at 10 V/cm. Electrophoresis proceeded for 5 h under identical conditions. Autoradiographs of the dried gels were exposed for 1 to 2 h at Ϫ80ЊC with intensifying screens.
Southwestern (protein-DNA) blotting. Southwestern blotting was performed by published methods (44) . Hepatic nuclear proteins (75 g) from hypophysectomized and GH-treated (15 min prior to sacrifice) rats were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (12.5% resolving gel). Following electrophoresis, the gel was equilibrated in transfer buffer (36) (48 mM Tris base, 39 mM glycine, 0.04% SDS, 20% methanol), and proteins were transferred to nitrocellulose (pore size, 0.2 m; Bio-Rad Laboratories), using a Bio-Rad semidry transblot unit at 22 V for 1 h. The membrane was blocked overnight in binding buffer described above, with 5% nonfat dried milk substituted for bovine serum albumin. After rinsing, the blot was incubated with 3 ϫ 10 6 cpm of Spi 2.1 probe in binding buffer at 25ЊC for 1 h, then further washed in binding buffer, air dried, and exposed to X-ray film with intensifying screens for up to 5 days at Ϫ80ЊC.
RESULTS
Previous studies have shown that GH treatment of hypophysectomized rats stimulated Spi 2.1 mRNA expression in the liver and have indicated that this effect is transcriptional (60) . Figure 1 demonstrates that GH rapidly activates Spi 2.1 gene expression. As assessed by RNase protection assay (Fig. 1A) , GH injection enhanced the appearance of correctly initiated nuclear Spi 2.1 transcripts within 15 min of injection to a peak level of 7.5-fold above the value for hypophysectomized rats by 30 to 60 min, followed by a decline by 120 min (50) . Thus, in agreement with results of nuclear run-on studies (51), GH rapidly activates hepatic Spi 2.1 gene transcription in vivo. In contrast, the abundance of mature albumin transcripts remained constant following GH injection (Fig. 1D) .
Since previous studies had identified a GH-inducible gel shift in an assay using a 45-bp DNA segment from the proximal promoter of the Spi 2.1 gene, we next sought to determine whether this DNA-protein interaction coincided with transcriptional activation. Results of a gel mobility shift experiment using the 45-bp Spi 2.1 probe (Table 1) are shown in Fig. 2A . As seen in lane 1, there is no gel-shifted band present with hepatic nuclear extracts from hypophysectomized rats. Within 15 min of GH administration, a DNA-protein complex appeared and persisted for up to 120 min following hormone treatment (lanes 2 to 5). By contrast, nuclear protein binding to several other cis elements, such as the Oct-1 (Fig. 2B) and HNF-1 (50) consensus sequences, were not acutely regulated by GH and served as a loading controls.
To show specificity of DNA-protein binding and to determine if the GH-inducible cis-acting element in the Spi 2.1 gene was related to the GH-activated GHIF or SIE (18, 23) , competition gel shift studies were performed (Fig. 3) . As seen in . Other SIE-related DNA sequences, including an oligonucleotide containing a GAS element from the gamma interferon-regulated enhancer of the Ly6 gene (27) and the natural mouse c-fos SIE (54), failed to compete for nuclear protein binding (lanes 5, 6, 9, and 10), and the unrelated Oct-1 oligonucleotide competitor also was ineffective (lanes 7 and 8).
The rapid induction of the Spi 2.1 DNA-protein complex following GH treatment is consistent with a posttranslational modification of the protein component stimulated by signaling from the activated GH receptor. Since JAK2 becomes an active protein tyrosine kinase after binding to the dimerized, activated GH receptor and phosphorylates cellular substrates, potentially including STAT proteins on tyrosine residues, we examined the effect of antiphosphotyrosine, antiphosphoserine, and antiphosphothreonine antibodies and polyclonal antisera to Stat1, Stat3, and Stat4 on the GH-inducible Spi 2.1 gel shift. Monoclonal antiphosphotyrosine antibodies (4G10 and PY20) inhibited the Spi 2.1 gel-shifted complex but did not produce a supershift (Fig. 4A, lane 2) , whereas antiphosphoserine, antiphosphothreonine, and anti-MAP kinase antibodies had no effect (Fig. 4A, lanes 3 to 5) . Examination of the nucleotide sequence of the Spi 2.1 oligonucleotide revealed two potential TT(N) 5 AA binding sites for STAT proteins (8) , and as shown in Fig. 3 , a high-affinity SIE oligonucleotide reduced binding of the Spi 2.1 probe to nuclear proteins. However, Stat1, Stat3, and Stat4 polyclonal antibodies did not inhibit or produce a supershift of the Spi 2.1 gel-shifted complex (Fig. 4A, lanes 6 to 8) . A monoclonal antibody for ISGF3, which recognizes Stat1, also had no effect (50) . In contrast, a GH-inducible gel shift seen with a high-affinity SIE probe and the same hepatic nuclear extracts was found to contain STAT proteins, as indicated by the appearance of supershifts with antisera to Stat1, Stat3, and Stat4 but not with an antibody to MAP kinase ( Fig. 4B and reference 19) . We next sought to identify the protein or proteins comprising the GH-inducible Spi 2.1 gel-shifted DNA-protein complex. A Southwestern blot was performed by hybridizing a 32 P-labeled Spi 2.1 double-stranded oligonucleotide with filterbound hepatic nuclear proteins from hypophysectomized and GH-treated rats (Fig. 5) . Among the proteins detected, a labeled band of ϳ41 kDa was seen after only 15 min of GH treatment and persisted for up to 120 min after GH injection (50) , in parallel with the GH-inducible gel shift. A smaller band of ϳ35 kDa also appeared to be GH inducible, although it could be detected in hepatic nuclear extracts from hypophysectomized rats.
DISCUSSION
GH-activated gene expression represents the last step in a signaling cascade from the cell surface GH receptor to the nucleus. In this report, we show that induction of Spi 2.1 gene transcription occurs within 15 min of systemic GH treatment. Gene activation coincides with GH-inducible DNA-protein binding to a segment of the Spi 2.1 promoter, and a pair of novel, hormone-activated nuclear proteins was identified by Southwestern blot with the 45-bp Spi 2.1 probe. Taken together, these results demonstrate that GH-stimulated nuclear signaling is rapid and that Spi 2.1 can be considered an earlyresponse gene to GH.
The kinetics of GH-stimulated nuclear protein binding to the Spi 2.1 promoter element and the rapid transcriptional activation of the Spi 2.1 gene parallel both GH-inducible binding of STAT proteins to the high-affinity and natural c-fos SIE and the rapid induction of c-fos transcription by GH that we have described recently (18, 19) (Fig. 4B) . However, although the high-affinity SIE competes for nuclear protein binding with the Spi 2.1 element by gel shift assay, polyclonal antisera to Stat1, Stat3, and Stat4 (and monoclonal anti-ISGF3 antibody) failed to abrogate the formation of the Spi 2.1 gel-shifted complex (Fig. 4A) , in contrast to the results seen with the SIE probe ( Fig. 4B and reference 19) . Further evidence which suggests that SIE and Spi 2.1 gel-shifted complexes are distinct comes from the results of Southwestern blots. As shown here, the Spi 2.1 probe detects GH-inducible 41-and 35-kDa proteins. SIE probes bind to nuclear proteins of 80 to 91 kDa. (A) Autoradiograph of a gel mobility shift experiment using a 32 P-labeled double-stranded oligonucleotide containing the GH-inducible Spi 2.1 cis element shown in Table 1 and 5.5 g of hepatic nuclear extracts from hypophysectomized (Hx) rats 0 to 120 min following a single injection of GH. The GH-inducible DNA-protein complex is indicated by the arrow. (B) Autoradiograph of a gel mobility shift experiment using a 32 P-labeled double-stranded oligonucleotide containing the Oct-1 consensus sequence shown in Table 1 and 6.0 g of hepatic nuclear extracts from hypophectomized (Hx) rats 0 to 60 min following a single injection of GH. The arrows on the right indicate complexes specific for Oct-1. Autoradiographic exposure was for 1 h (A) or 2 h (B) at Ϫ80ЊC with intensifying screens. FP, free probe.
FIG. 3.
A high-affinity SIE oligonucleotide competes for nuclear protein binding with the Spi 2.1 GH-inducible element. Shown is an autoradiograph of a gel mobility shift assay performed with a Spi 2.1 oligonucleotide probe and hepatic nuclear extract from GH-treated hypophysectomized rats, using conditions described in Materials and Methods. Lane 1 shows a standard gel shift. Lane 2 contains a 10ϫ molar excess of unlabeled rat Spi 2.1 oligonucleotide. Lanes 3 and 4 contain 10ϫ and 50ϫ molar excesses of unlabeled high-affinity SIE (ha-SIE) oligonucleotide. Lanes 5 and 6 contain 10ϫ and 50ϫ molar excesses of unlabeled mouse Ly6 oligonucleotide. Lanes 7 and 8 contain 10ϫ and 50ϫ molar excesses of an unlabeled Oct-1 concensus oligonucleotide, and lanes 9 and 10 contain 10ϫ and 50ϫ molar excesses of natural c-fos SIE oligonucleotide. Autoradiographic exposure was for 1.5 h at Ϫ80ЊC with intensifying screens.
VOL. 15, 1995 RAPID GH INDUCTION OF RAT Spi 2. 1 15 Gel mobility shift competition experiments showed that the high-affinity SIE blocked the Spi 2.1 gel shift; however, the natural SIE of the c-fos promoter and Ly6 enhancer element, which contain similar consensus sequences, were ineffective competitors. Even though the Spi 2.1 oligonucleotide contains two GAS-like elements (TTCTACTAA and TTCTGAGAA [59] ), our data suggest that these sequences do not bind Stat1, -3, or -4 (Fig. 4A) . The high-affinity SIE probe may have inhibited the Spi 2.1 gel-shifted complex because of interactions with nuclear proteins other than STAT factors. In this regard, it is notable that regions of sequence similarity in addition to the GAS sites exist between the high-affinity SIE and Spi 2.1 probes (e.g., AAATC[A/G]TC). Interestingly, unlabeled Spi 2.1 competitor will block formation of the SIE gel shift, though it is not as effective a competitor as the highaffinity SIE (50) .
Taken as a whole, the results of our studies suggest that there are divergent signal transduction pathways initiated by the binding of GH to its receptor. Even though the kinetics of mRNA induction are similar for Spi 2.1 and c-fos genes (19) , the GH-activated DNA-binding proteins appear to be different. The point of divergence between Spi 2.1 and c-fos pathways is not known, although in both cases, nuclear factors may require tyrosine phosphorylation for activation of DNA binding. This has been demonstrated for Stat1, as tyrosine phosphorylation is critical for nuclear translocation, dimerization, and DNA binding (39) and may be required by the Spi 2.1 factor, as an antiphosphotyrosine antibody inhibits the GHinducible gel shift (Fig. 4A ). In conjunction with this observation, in previous studies we have identified GH-inducible tyrosine phosphorylation of nuclear proteins of ϳ41 kDa (18) , similar in size to one of the bands detected by Southwestern blotting using the Spi 2.1 DNA probe (Fig. 5) . The results seen with c-fos and Spi 2.1 further contrast with the situation observed for another GH-activated gene, IGF-I. IGF-I gene transcription is also rapidly stimulated by GH treatment, and the gene contains a GH-inducible chromatin alteration, but no change in DNA-protein binding has been identified within this region, and its nucleotide sequence does not resemble that of the SIE or the Spi 2.1 promoter element (51) . Thus, the activated GH receptor may induce distinct nuclear signal transduction pathways to mediate specific regulation of different target genes.
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